Evaluation of the E/e' Ratio of the Mitral Annulus in Predicting Fluid Responsiveness.
1 other identifier
interventional
70
1 country
1
Brief Summary
Diastolic function may be evaluated by different measurements on transesophageal echocardiography (TEE). They include mitral inflow velocities obtained by pulsed-wave doppler (PW) : peak early diastolic velocity (E) and late diastolic velocity (A). Mitral annulus velocities, early diastolic (e') and late diastolic (a') are obtained by tissue doppler imaging (TDI). The ratio E/e' reflects left ventricular filling pressure and, as such, might be a predictor of fluid responsiveness. The aim of this study is to evaluate the predictive value of the mitral valve E/e' ratio for fluid responsiveness among patients undergoing coronary bypass graft surgery. Fluid responsiveness being defined as an increase in stroke volume of ≥ 15%. After induction of anesthesia, patients will have their diastolic function evaluated by means of E/e' and other measures. They will then be administered an intravenous bolus of 500 mL of Lactate Ringer® along with passive leg raising (PLR). Stroke volume and fluid responsiveness will be assessed by the thermodilution method (Swan-Ganz catheter) and the FloTrac® device. Fluid responders will be compared to non-responders to evaluate the relationship between E/e' ratio and fluid responsiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
March 3, 2016
CompletedFirst Posted
Study publicly available on registry
March 21, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedSeptember 7, 2017
December 1, 2016
1.6 years
March 3, 2016
September 6, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Mitral valve E/e' ratio for prediction of fluid responsiveness
TEE evaluation of mitral inflow velocities and mitral annulus velocities measured right before fluid administration as a predictor of fluid responsiveness defined as an increase of 15% or more of the stroke volume
TEE images taken within the 15 minutes before fluid administration and responsiveness evaluation within the 5 minutes following fluid administration and leg raising
Secondary Outcomes (3)
Pulmonary capillary wedge pressure (PCWP) a-wave to v-wave ratio of the for prediction of fluid responsiveness
Waveform measured within the 15 minutes preceding fluid administration and responsiveness evaluation within the 5 minutes following fluid administration and leg raising
Pulse pressure variation (PPV) for prediction of fluid responsiveness
PPV measured within the 15 minutes preceding fluid administration and responsiveness evaluation within the 5 minutes following fluid administration and leg raising
Stroke volume variation (SVV) for prediction of fluid responsiveness
SVV measured within the 15 minutes preceding fluid administration and responsiveness evaluation within the 5 minutes following fluid administration and leg raising
Interventions
Volume expansion with rapid administration of 500 ml of crystalloid
Eligibility Criteria
You may qualify if:
- Patients \>18 yrs, undergoing elective coronary artery bypass grafting or surgery will be included.
You may not qualify if:
- Significant mitral valvular heart disease (mitral regurgitation ≥ 2/4 or stenosis)
- Significant right sided valvular heart disease (tricuspid regurgitation ≥ 2/4)
- Intracardiac shunts
- Emergency surgery
- Non-sinusal rythme
- Clinical evidence of decompensated heart failure
- Clinical evidence of decompensated pulmonary hypertension
- Renal insufficiency with creatinine clairance ≤ 30 cc/min or dialysis
- Contraindications to TEE, including esophageal disease or unstable cervical spine
- CVP ≥ 15 mm Hg or PCWP ≥ 18 mm Hg immediately before fluid infusion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Montreal Heart Institute
Montreal, Quebec, H1T 1C8, Canada
Related Publications (1)
Courbe A, Perrault-Hebert C, Ion I, Desjardins G, Fortier A, Denault A, Deschamps A, Couture P. Should we use diastolic function parameters to determine preload responsiveness in cardiac surgery? A pilot study. J Anesth Analg Crit Care. 2021 Oct 30;1(1):12. doi: 10.1186/s44158-021-00014-7.
PMID: 37386580DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 3, 2016
First Posted
March 21, 2016
Study Start
January 1, 2016
Primary Completion
August 1, 2017
Study Completion
August 1, 2017
Last Updated
September 7, 2017
Record last verified: 2016-12
Data Sharing
- IPD Sharing
- Will not share